2021 research period for North America is officially open
March 24, 2021
Research team is now accepting firm submissions, due June 1
US
General Patent Litigation
| General Patent Litigation — Recommended |
|---|
| Arnold & Porter |
| Cooley |
| Covington & Burling |
| Durie Tangri |
| Gibson Dunn & Crutcher |
| Knobbe Martens |
| Mayer Brown |
| McAndrews Held & Malloy |
| Morgan Lewis & Bockius |
| Sterne Kessler Goldstein & Fox |
| Venable |
| Weil Gotshal & Manges |
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Baughman, Steven | Intellectual Property | General Patent Litigation | Washington, D.C. |
| Groombridge, Nicholas | Intellectual Property | Patent Strategy & Management, General Patent Litigation, Hatch-Waxman Patent Litigation | New York City |
| Stone, Eric | Intellectual Property | General Patent Litigation | New York City |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Intellectual Property
Paul Weiss Rifkind Wharton & Garrison
Paul Weiss Rifkind Wharton & Garrison is highly ranked for its strength in general patent litigation, notably in biosimilars disputes and post-grant proceedings. "Their trial attorneys have a deep understanding of the technology at issue and are quick on their feet," a peer says. Paul Weiss has one of the pioneering practices in biosimilars litigation, a continuing area of focus for the firm.
The firm's position as a leading practice in the large molecule space is in part due to litigator Nicholas Groombridge, an IP trial lawyer with more than 25 years of experience. He also has deep experience in patent disputes related to pharmaceuticals and medical devices. Groombridge was shortlisted as the New York General Patent Litigator of the Year in 2020 by LMG Life Sciences.
DC-based partner Steven Baughman is a leading practitioner for post-grant proceedings. His past representations include IPRs for Nevro Corporation and Chugai Pharmaceutical. Eric Stone is another standout in the firm's roster of stars for his significant work in patent litigations involving large and small molecule products.